Your browser doesn't support javascript.
loading
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
Parry, Erin M; Leshchiner, Ignaty; Guièze, Romain; Johnson, Connor; Tausch, Eugen; Parikh, Sameer A; Lemvigh, Camilla; Broséus, Julien; Hergalant, Sébastien; Messer, Conor; Utro, Filippo; Levovitz, Chaya; Rhrissorrakrai, Kahn; Li, Liang; Rosebrock, Daniel; Yin, Shanye; Deng, Stephanie; Slowik, Kara; Jacobs, Raquel; Huang, Teddy; Li, Shuqiang; Fell, Geoff; Redd, Robert; Lin, Ziao; Knisbacher, Binyamin A; Livitz, Dimitri; Schneider, Christof; Ruthen, Neil; Elagina, Liudmila; Taylor-Weiner, Amaro; Persaud, Bria; Martinez, Aina; Fernandes, Stacey M; Purroy, Noelia; Anandappa, Annabelle J; Ma, Jialin; Hess, Julian; Rassenti, Laura Z; Kipps, Thomas J; Jain, Nitin; Wierda, William; Cymbalista, Florence; Feugier, Pierre; Kay, Neil E; Livak, Kenneth J; Danysh, Brian P; Stewart, Chip; Neuberg, Donna; Davids, Matthew S; Brown, Jennifer R.
Afiliación
  • Parry EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Leshchiner I; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Guièze R; Harvard Medical School, Boston, MA, USA.
  • Johnson C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Tausch E; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
  • Parikh SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lemvigh C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Broséus J; CHU de Clermont-Ferrand, Clermont-Ferrand, France.
  • Hergalant S; Université Clermont Auvergne, EA7453 CHELTER, Clermont-Ferrand, France.
  • Messer C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Utro F; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Levovitz C; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Rhrissorrakrai K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Li L; Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Rosebrock D; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.
  • Yin S; Université de Lorraine, CHRU-Nancy, service d'hématologie biologique, pôle laboratoires, Nancy, France.
  • Deng S; Inserm UMRS1256 Nutrition-Génétique et Exposition aux Risques Environnementaux (N-GERE), Université de Lorraine, Nancy, France.
  • Slowik K; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Jacobs R; IBM Research, Yorktown Heights, New York, NY, USA.
  • Huang T; IBM Research, Yorktown Heights, New York, NY, USA.
  • Li S; IBM Research, Yorktown Heights, New York, NY, USA.
  • Fell G; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Redd R; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Lin Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Knisbacher BA; Harvard Medical School, Boston, MA, USA.
  • Livitz D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Schneider C; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Ruthen N; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Elagina L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Taylor-Weiner A; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Persaud B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Martinez A; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Fernandes SM; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Purroy N; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Anandappa AJ; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ma J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Hess J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Rassenti LZ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Kipps TJ; Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Jain N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wierda W; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Cymbalista F; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Feugier P; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Kay NE; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Livak KJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Danysh BP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Stewart C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Neuberg D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Davids MS; Harvard Medical School, Boston, MA, USA.
  • Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Nat Med ; 29(1): 158-169, 2023 01.
Article en En | MEDLINE | ID: mdl-36624313
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Linfoma de Células B Grandes Difuso Tipo de estudio: Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Linfoma de Células B Grandes Difuso Tipo de estudio: Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos